Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $577.37 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $153.90 | 12 | $0 (2020) |
| Amgen Inc. | $85.19 | 5 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $59.02 | 3 | $0 (2024) |
| Foundation Medicine, Inc. | $49.21 | 2 | $0 (2019) |
| Roche Diagnostics Corporation | $46.83 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $29.90 | 2 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $26.42 | 2 | $0 (2018) |
| Clovis Oncology, Inc. | $18.27 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $16.29 | 1 | $0 (2020) |
| INSYS Therapeutics Inc | $15.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.41 | 2 | AstraZeneca Pharmaceuticals LP ($20.00) |
| 2020 | $29.91 | 2 | Merck Sharp & Dohme Corporation ($16.29) |
| 2019 | $272.87 | 15 | Amgen Inc. ($70.72) |
| 2018 | $159.40 | 12 | EMD Serono, Inc. ($97.89) |
| 2017 | $79.78 | 6 | Clovis Oncology, Inc. ($18.27) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2018 | Agios Pharmaceuticals, Inc. | IDHIFA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Oncology | ||||||
| 03/23/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Oncology | ||||||
| 03/23/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Oncology | ||||||
| 03/02/2018 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Oncology | ||||||
| 01/11/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Oncology | ||||||
| 10/06/2017 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Hematology/Oncology | ||||||
| 08/30/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Immunology | ||||||
| 08/18/2017 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 07/14/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Oncology | ||||||
| 05/17/2017 | Sysmex America, Inc. | XN Series (Device) | Food and Beverage | Cash or cash equivalent | $6.89 | General |
| Category: Hematology | ||||||
| 04/21/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Breakthrough Cancer Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,286 | 2,021 | $460,845 | $44,257 |
| 2022 | 18 | 1,493 | 2,414 | $565,707 | $55,480 |
| 2021 | 16 | 1,180 | 1,765 | $407,747 | $41,790 |
| 2020 | 16 | 767 | 1,269 | $330,352 | $34,001 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 85097 | Bone marrow, smear interpretation | Facility | 2022 | 39 | 41 | $8,856 | $1,689 | 19.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 98 | 132 | $28,512 | $1,273 | 4.5% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2022 | 15 | 15 | $3,465 | $1,225 | 35.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 45 | 118 | $22,253 | $1,201 | 5.4% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 19 | 21 | $7,833 | $1,067 | 13.6% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 12 | 17 | $8,534 | $575.40 | 6.7% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 22 | 24 | $7,896 | $545.86 | 6.9% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2022 | 18 | 22 | $6,710 | $501.62 | 7.5% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2022 | 15 | 15 | $2,160 | $323.88 | 15.0% |
| 88363 | Examination of archival tissue for genetic analysis | Facility | 2022 | 12 | 12 | $2,712 | $198.04 | 7.3% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2022 | 22 | 25 | $2,700 | $101.79 | 3.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 208 | 332 | $107,236 | $10,232 | 9.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 65 | 329 | $113,505 | $7,854 | 6.9% |
| 84165 | Protein measurement, serum | Facility | 2021 | 224 | 268 | $9,916 | $4,271 | 43.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 86 | 92 | $31,740 | $2,665 | 8.4% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2021 | 37 | 40 | $30,440 | $2,540 | 8.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2021 | 26 | 35 | $20,055 | $2,454 | 12.2% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2021 | 132 | 143 | $5,291 | $2,262 | 42.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2021 | 157 | 183 | $17,202 | $1,967 | 11.4% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2021 | 20 | 20 | $4,620 | $1,708 | 37.0% |
| 88374 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | Facility | 2021 | 13 | 41 | $8,610 | $1,492 | 17.3% |
| 85097 | Bone marrow, smear interpretation | Facility | 2021 | 30 | 30 | $6,480 | $1,277 | 19.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2021 | 79 | 105 | $22,680 | $1,035 | 4.6% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2021 | 33 | 36 | $11,820 | $838.79 | 7.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 35 | 71 | $13,277 | $741.87 | 5.6% |
About Dr. Vathany Sriganeshan, MD
Dr. Vathany Sriganeshan, MD is a Anatomic Pathology healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679794671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vathany Sriganeshan, MD has received a total of $577.37 in payments from pharmaceutical and medical device companies, with $35.41 received in 2024. These payments were reported across 37 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($577.37).
As a Medicare-enrolled provider, Sriganeshan has provided services to 4,726 Medicare beneficiaries, totaling 7,469 services with total Medicare billing of $175,527. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine
- Location Miami Beach, FL
- Active Since 05/01/2007
- Last Updated 12/11/2017
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1679794671
Products in Payments
- Bavencio (Biological) $140.28
- Neulasta (Biological) $66.80
- FOUNDATIONACT (Device) $49.21
- OPDIVO (Biological) $29.90
- TD VENTANA Digital Pathology Products (Device) $26.15
- TD BenchMark IHC/ISH and Special Stains Reagents (Device) $20.68
- WAINUA (Drug) $20.00
- MVASI (Biological) $18.39
- Rubraca (Drug) $18.27
- TAGRISSO (Drug) $17.86
- KEYTRUDA (Biological) $16.29
- SUBSYS (Drug) $15.85
- JAKAFI (Drug) $15.47
- SYLVANT (Drug) $15.41
- IDHIFA (Drug) $13.75
- Bavencio (Drug) $13.62
- Sylvant (Biological) $12.66
- Xermelo (Drug) $12.31
- SOLIRIS (Drug) $10.99
- XN Series (Device) $6.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.